Category: CBD Stocks
7 Best CBD Wholesale Companies in the UK 2026
The UK CBD wholesale market has matured considerably in 2026. Businesses looking to stock CBD products, whether they are retailers,…
Pure Canna Organics Revolutionizes Affordable Wellness with Premium CBD Products
BEND, OR / ACCESS Newswire / February 28, 2026 / Pure Canna Organics is redefining the wellness industry by offering…
Jazz Pharmaceuticals’ CBD Drug Hits $1B: Time to Buy the Stock?
JAZZ CBD drug Epidiolex tops $1B in annual sales, boosting revenue visibility and cannabis exposure. Is the biotech’s growth story…
Beyond CBD: Kyoto Botanicals Launches Sugar-Free Mushroom Brew
(re)GROUND Mushroom + Cacao Adaptogenic Brew is available in a 28-serving jar and is vegan, gluten-free, sugar-free and third-party tested…
Here’s why I wouldn’t touch Tilray with a 10‑foot pole
Tilray Brands is expanding its business at a rapid clip, but there are risks associated with this growth effort.
Global CBD Skin Care Market Projected to Reach USD 58.1 Billion by 2036 Driven by Innovation and Premiumization
The global CBD skincare market will expand from USD 6.6 billion in 2026 to USD 58.1 billion by 2036 |…
TruFull CBD Gummies: Product Disclosure Information Updated as CBD Supplement Research Grows in 2026
Examining hemp-derived CBD supplement disclosures, third-party testing verification, THC-free claims, ingredient transparency, refund policies, and what consumers evaluate when researching…
TruFull CBD Gummies | Launch “CBD Gummies Safe Relieves Anxiety Effective Reduces Pain & Stress With TruFull CBD 2026
A trusted, hemp-based CBD supplement created to help manage stress, and support physical comfort safely.New York City, Feb. 04, 2026…
High Tide Inc. (HITI): Among high growth Canadian stocks to buy
We recently published an article titled 9 High Growth Canadian Stocks to Buy. High Tide Inc. (NASDAQ:HITI), founded in 2009,…
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
Gregory D. Gorgas, Chief Executive Officer of Artelo, added, “ART12.11 was purpose-built to meet the standards required for federal healthcare…
Recent Comments